WKHS Locations

Clinical Trials

Prophylactic Intervention on Bone Pain in Breast Cancer

Study Title

Prophylactic Intervention on Bone Pain in Breast Cancer

Purpose

To compare the difference across cycles of bone pain between treatment groups in patients receiving chemotherapy and Neulasta

Eligibility

Female patients at least 18 years old

Newly diagnosed, Stage I-III Breast Cancer

Not previously treated for Breast Cancer

No history of other malignancy within the past 5 years

Study Process

Treatment Period: Planning to receive at least 4 cycles of chemotherapy

All subjects will be asked to complete a brief bone pain survey each day for the first 5 days of every chemotherapy cycle

Prophylactic medication will be provided by study sponsor

Trial Details

Principal Investigator:

Maxwell McDonald, M.D.

IRB:

Willis-Knighton

IRB Number:

13.0001

Trial Type:

Drug

Sponsor:

Amgen

Contact Information:

Hematology Oncology Associates
(318) 212-8620
http://cancer.wkhs.com